Literature DB >> 29982355

Evaluating Mobility in Advanced Dementia: A Scoping Review and Feasibility Analysis.

Karen Van Ooteghem1, Kristin Musselman1,2, David Gold3,4, Meghan N Marcil1, Ron Keren1,4,5, Maria Carmela Tartaglia6,7, Alastair J Flint4,5, Andrea Iaboni1,4,5.   

Abstract

BACKGROUND AND OBJECTIVES: Mobility decline is a symptom of advanced dementia that affects function, safety, caregiving, and quality of life. Monitoring mobility status is essential for initiating timely and targeted interventions aimed at preventing excess disability in people with dementia (PWD). The physical, cognitive, and behavioral symptoms of dementia however, present unique challenges for mobility assessment. The goals of this review were to (a) identify and describe measures of mobility used for PWD and (b) assess measures' feasibility for use in people with advanced dementia; a group whose degree of cognitive impairment results in severe functional deficits. RESEARCH DESIGN AND METHODS: Electronic searches of Medline, Embase, CINAHL, and PsychInfo databases were conducted using keywords related to dementia, mobility, measurement, and validation. Descriptive characteristics were extracted and measures coded for mobility components. Tools were also evaluated for feasibility of use in advanced dementia and those deemed feasible, screened for psychometric strength.
RESULTS: Thirty-eight measures were included and 68% of these tools were performance-based. Elements of mobility evaluated were walking (53% of measures), postural transitions (42%), standing (40%), mobility-related behavioral/psychological symptoms (24%), transfers (10%), bed mobility (5%), and wheeled mobility (3%). 36% of studies included people with advanced dementia. Only 18% of tools received high scores for feasibility. DISCUSSION AND IMPLICATIONS: Existing measures provide only partial information regarding mobility and few target elements that become relevant as dementia progresses. Most measures are not feasible for people with advanced dementia, and the psychometric evaluation of these measures is limited. Further research is needed to develop a comprehensive, dementia-specific, mobility assessment tool.
© The Author(s) 2018. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s disease; Dementia; Function/mobility; Geriatrics

Mesh:

Year:  2019        PMID: 29982355     DOI: 10.1093/geront/gny068

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  4 in total

1.  Measuring Gait Variables Using Computer Vision to Assess Mobility and Fall Risk in Older Adults With Dementia.

Authors:  Kimberley-Dale Ng; Sina Mehdizadeh; Andrea Iaboni; Avril Mansfield; Alastair Flint; Babak Taati
Journal:  IEEE J Transl Eng Health Med       Date:  2020-05-28       Impact factor: 3.316

2.  Integrating Technology Into Clinical Practice for the Assessment of Balance and Mobility: Perspectives of Exercise Professionals Practicing in Retirement and Long-term Care.

Authors:  Karen Van Ooteghem; Avril Mansfield; Elizabeth L Inness; Jaimie Killingbeck; Kathryn M Sibley
Journal:  Arch Rehabil Res Clin Transl       Date:  2020-01-16

3.  Evaluation of Clinical Practice Guidelines on Fall Prevention and Management for Older Adults: A Systematic Review.

Authors:  Manuel M Montero-Odasso; Nellie Kamkar; Frederico Pieruccini-Faria; Abdelhady Osman; Yanina Sarquis-Adamson; Jacqueline Close; David B Hogan; Susan Winifred Hunter; Rose Anne Kenny; Lewis A Lipsitz; Stephen R Lord; Kenneth M Madden; Mirko Petrovic; Jesper Ryg; Mark Speechley; Munira Sultana; Maw Pin Tan; N van der Velde; Joe Verghese; Tahir Masud
Journal:  JAMA Netw Open       Date:  2021-12-01

4.  Social integration and loneliness among long-term care home residents: protocol for a scoping review.

Authors:  Jennifer Bethell; Jessica Babineau; Andrea Iaboni; Robin Green; Rachelle Cuaresma-Canlas; Roobika Karunananthan; Barbara Schon; Denise Schon; Katherine S McGilton
Journal:  BMJ Open       Date:  2019-12-09       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.